NFE2L2 and amyotrophic lateral sclerosis: Previous studies have indicated that the Keap1-Nrf2 pathway, involving the transcription factor Nrf2 and its repressor protein Keap1, is altered in animal models of ALS (Mimoto et al., 2012) and post mortem tissues from patients (Sarlette et al., 2008).